stockrowViatris Inc. (VTRS) vs Zoetis Inc. (ZTS)
- Viatris Inc. VTRS 18.89 −1.72%
- Zoetis Inc. ZTS 81.72 −8.39%
Viatris Inc. and Zoetis Inc. are both Drug Manufacturers Specialty & Generic companies. Zoetis Inc. is the larger, with a market value of $33.9B against $21.8B — 1.6× the size. Viatris Inc. has negative trailing earnings, so its P/E is not meaningful; Zoetis Inc. trades at 13.4×. Viatris Inc. grew revenue faster over the last twelve months: 4.27% against 1.58%. Zoetis Inc. has the higher net margin (27.7% vs −4.13%) and the higher return on invested capital (19.6% vs −0.02%). Both pay a dividend; Zoetis Inc. yields more (2.59% vs 2.54%). Across the 22 metrics below, Zoetis Inc. leads on 15 and Viatris Inc. on 7.
Valuation
Profitability
| Metric | VTRS | ZTS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 35.31% | 71.67% | 53.51% |
| Operating margin | (0.03%) | 37.13% | 0.00% |
| Net margin | (4.13%) | 27.69% | (2.45%) |
| Free cash flow margin | 16.27% | 24.43% | 0.00% |
| Return on equity | (4.21%) | 64.91% | (0.80%) |
| Return on assets | (1.67%) | 17.84% | (1.67%) |
| Return on invested capital | (0.02%) | 19.60% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack